UNSPSC 85811303: Introduction of other antineoplastic into pericardial cavity, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into pericardial cavity, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0Y705

UNSPSC 85811303 Introduction of other antineoplastic into pericardial cavity, via natural or artificial opening (Commodity) does not align with the actual scope of state and local government procurement activity posted under this code in the recent opportunities block. The code nominally describes a medical procedure — injection of cancer-fighting agents directly into the fluid sac surrounding the heart — yet the recent solicitations tagged with this code span virtual urgent care, medical services contracting, nursing home operations, occupational health screening, cancer registry services, and EMS billing services, none of which involve pericardial cavity drug administration. State and local procurement systems appear to have misclassified these opportunities.

The mismatch between the UNSPSC code's clinical scope and the work actually being solicited raises a flag: this code shows little relevant recent activity when filtered to its intended procedure domain. The recent opportunities listed are general healthcare services, behavioral health, occupational medicine, and administrative health functions — categories that do not map to the highly specialized interventional oncology procedure the code describes. A business development professional targeting antineoplastic drug delivery services for pericardial administration would find this code an unreliable signal of state and local purchasing demand, as the tagged opportunities do not reflect the service line. Pursuit of opportunities under this code requires verification that the issuing body actually intends to procure pericardial antineoplastic services rather than relying on the UNSPSC tag alone.